Prior data assisted compressed sensing: a novel MR imaging strategy for real time tracking of lung tumors.

Med Phys

Department of Physics, University of Alberta, 11322 - 89 Avenue, Edmonton, Alberta T6G 2G7, Canada; Department of Medical Physics, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta T6G 1Z2, Canada; and Department of Oncology, Medical Physics Division, University of Alberta, 11560 Un

Published: August 2014


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: Hybrid radiotherapy-MRI devices promise real time tracking of moving tumors to focus the radiation portals to the tumor during irradiation. This approach will benefit from the increased temporal resolution of MRI's data acquisition and reconstruction. In this work, the authors propose a novel spatial-temporal compressed sensing (CS) imaging strategy for the real time MRI--prior data assisted compressed sensing (PDACS), which aims to improve the image quality of the conventional CS without significantly increasing reconstruction times.

Methods: Conventional 2D CS requires a random sampling of partial k-space data, as well as an iterative reconstruction that simultaneously enforces the image's sparsity in a transform domain as well as maintains the fidelity to the acquired k-space. PDACS method requires the additional acquisition of the prior data, and for reconstruction, it additionally enforces fidelity to the prior k-space domain similar to viewsharing. In this work, the authors evaluated the proposed PDACS method by comparing its results to those obtained from the 2D CS and viewsharing methods when performed individually. All three methods are used to reconstruct images from lung cancer patients whose tumors move and who are likely to benefit from lung tumor tracking. The patients are scanned, using a 3T MRI, under free breathing using the fully sampled k-space with 2D dynamic bSSFP sequence in a sagittal plane containing lung tumor. These images form a reference set for the evaluation of the partial k-space methods. To create partial k-space, the fully sampled k-space is retrospectively undersampled to obtain a range of acquisition acceleration factors, and reconstructed with 2D-CS, PDACS, and viewshare methods. For evaluation, metrics assessing global image artifacts as well as tumor contour shape fidelity are determined from the reconstructed images. These analyses are performed both for the original 3T images and those at a simulated 0.5T equivalent noise level.

Results: In the 3.0T images, the PDACS strategy is shown to give superior results compared to viewshare and conventional 2D CS using all metrics. The 2D-CS tends to perform better than viewshare at the low acceleration factors, while the opposite is true at the high acceleration factors. At simulated 0.5T images, PDACS method performs only marginally better than the viewsharing method, both of which are superior compared to 2D CS. The PDACS image reconstruction time (0.3 s/image) is similar to that of the conventional 2D CS.

Conclusions: The PDACS method can potentially improve the real time tracking of moving tumors by significantly increasing MRI's data acquisition speeds. In 3T images, the PDACS method does provide a benefit over the other two methods in terms of both the overall image quality and the ability to accurately and automatically contour the tumor shape. MRI's data acquisition may be accelerated using the simpler viewsharing strategy at the lower, 0.5T magnetic field, as the marginal benefit of the PDACS method may not justify its additional reconstruction times.

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.4885960DOI Listing

Publication Analysis

Top Keywords

pdacs method
24
real time
16
compressed sensing
12
time tracking
12
mri's data
12
data acquisition
12
partial k-space
12
acceleration factors
12
images pdacs
12
pdacs
10

Similar Publications

Purpose: Oncogenic mutations in Kirsten rat sarcoma virus are present in over 90% of pancreatic ductal adenocarcinomas (PDACs). Preclinical data suggest that PDAC cells treated with inhibitors of the mitogen-activated protein kinase pathway demonstrate elevated autophagic flux. In this study, we evaluate the clinical efficacy of combining LY3214996 (extracellular regulated kinase inhibitor) with hydroxychloroquine (HCQ; autophagy inhibitor) in patients with metastatic PDAC.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) exhibits a distinctive propensity to invade nearby organs and infiltrate large blood vessels, even in the absence of distant metastasis. While the genetic and transcriptomic drivers of PDAC progression have been well studied, the mechanisms by which these molecular changes translate into functional, invasive behavior remain largely unknown. Here, we uncover a striking level of tissue organization, characterized by previously unrecognized spatial and geometric properties within and among tumor structures.

View Article and Find Full Text PDF

Background: Stage IIB or III pancreatic ductal adenocarcinoma (PDAC) includes patients with varying tumor sizes and numbers of nodal metastases. This study aimed to stratify the prognoses of patients with stage IIB and III PDACs by tumor size and number of nodal metastases.

Methods: This study included patients who underwent pancreatectomy for node-positive stage IIB or III PDAC between January 2006 and December 2021.

View Article and Find Full Text PDF

Pancreatic adenocarcinoma (PDAC) is a rapidly progressing cancer that responds poorly to immunotherapies. Intratumoral tertiary lymphoid structures (TLS) have been associated with rare long-term PDAC survivors, but the role of TLS in PDAC and their spatial relationships within the context of the broader tumor microenvironment remain unknown. Herein, we report the generation of a spatial multi-omics atlas of PDAC tumors and tumor-adjacent lymph nodes from patients treated with combination neoadjuvant immunotherapies.

View Article and Find Full Text PDF

Introduction: Pancreatic cancer (PC) is the third leading cause of cancer-related death in Canada. Risk factors for the development of PC are not well defined and there is limited data on the role of pancreatitis as a risk factor for PC. Here we aimed at evaluating this relationship in a meta-analysis.

View Article and Find Full Text PDF